article placeholder

FDA approves antibacterial agent Dalvance

The FDA has recently approved the antibacterial agent dalbavancin (Dalvance) for treatment of adult skin infections. Dalvance, marketed by the Chicago-based Durata Therapeutics,  is meant to treat acute bact...